Sintx Technologies, Inc. entered into a letter agreement with MedTech Ceramics, LP to restructure a previous warrant inducement transaction from September 2025. The agreement involves issuing 255,267 shares of common stock from abeyance and replacing the remaining 251,987 abeyance shares with a pre-funded warrant, while also replacing an existing warrant with a new warrant to purchase 1,268,135 shares at $2.14 per share. Sintx Technologies, Inc. operates in the medical technology industry, providing advanced ceramic materials for medical applications.
